Delta-Fly Pharma Balance Sheet Health
Financial Health criteria checks 6/6
Delta-Fly Pharma has a total shareholder equity of ¥1.7B and total debt of ¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ¥1.8B and ¥92.0M respectively.
Key information
0%
Debt to equity ratio
JP¥0
Debt
Interest coverage ratio | n/a |
Cash | JP¥1.73b |
Equity | JP¥1.69b |
Total liabilities | JP¥92.00m |
Total assets | JP¥1.78b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 4598's short term assets (¥1.7B) exceed its short term liabilities (¥91.0M).
Long Term Liabilities: 4598's short term assets (¥1.7B) exceed its long term liabilities (¥1,000.0K).
Debt to Equity History and Analysis
Debt Level: 4598 is debt free.
Reducing Debt: 4598 has no debt compared to 5 years ago when its debt to equity ratio was 0.5%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 4598 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 4598 has sufficient cash runway for 1.1 years if free cash flow continues to reduce at historical rates of 4.6% each year.